Optimizing Outcomes of Rectal Cancer in 2019 (C)

This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer. Learn more about ACS Accreditation/Verification Requirements.

Session Description

Management of rectal cancer is becoming increasingly challenging with growing options for local management and nonoperative management of patients after neoadjuvant chemoradiotherapy with complete clinical response. This panel will provide an update on the rapidly changing landscape of rectal cancer management.

Moderator: Steven D. Wexner, MD, PhD(Hon), FACS, FRCSEng, FRCSEd, FRCSI(Hon), FRCSGlasg(Hon), Weston, FL

Co-Moderator: Arden M. Morris, MD, MPH, FACS, Stanford, CA

Presentations

Introduction
Steven D. Wexner, MD, PhD(Hon), FACS, FRCSEng, FRCSEd, FRCSI(Hon), FRCSGlasg(Hon), Weston, FL

Arden M. Morris, MD, MPH, FACS, Stanford, CA

The Value of the American College of Surgeons Commission on Cancer National Accreditation Program for Rectal Cancer Accreditation
Heidi Nelson, MD, FACS, Chicago, IL

Should Adjuvant Chemotherapy Be Replaced by Neoadjuvant Therapy?
George J. Chang, MD, FACS, Houston, TX

The Rationale and Current Status of Wait and Watch after Complete Response
Julio E. Garcia-Aguilar, MD, FACS, New York, NY

How Collaboratives Improve Rectal Cancer Care
Samantha K. Hendren, MD, FACS, Ann Arbor, MI

Sponsored by the Advisory Council for Colon and Rectal Surgery and the Advisory Council for General Surgery

Target Audience

  • Practicing surgeons
  • Residents

Learning Objectives

  • Apply new knowledge and ideas to improve their surgical practice
  • Adapt concepts and quality measures in support of research advancements
  • Enhance the quality of patient care

Contact

For questions about the course, please contact elearning@facs.org.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Certificate of Completion
  • 1.50 Self Assessment Credit
Course opens: 
11/15/2019
Course expires: 
02/28/2021

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.

(Download the full list of disclosures).

Faculty and Disclosures

Arden M. Morris MD, MPH, FACS - Nothing to Disclose
George J. Chang, MD, FACS - Johnson and Johnson: Consulting Fee: Consultant; MOREHealth: Consulting Fee: Consultant
Heidi Nelson MD, FACS - Nothing to Disclose
Julio E. Garcia-Aguilar MD, FACS - Nothing to Disclose
Samantha K. Hendren MD, FACS - Nothing to Disclose
Steven D. Wexner, MD, PhD (Hon), FACS, FRCS (Eng), FRCS(Ed), FRCSI (Hon), Hon FRCS (Glasg) - Intuitive Surgical: Royalty payments and consulting fees: Intellectual property license and consulting; Karl Storz Endoscopy: Royalty payments and consulting fees: Intellectual property license and consulting; Medtronic: Royalty payments and consulting fees: Intellectual property license and consulting; Regentys: Consulting Fee: Consultant/Chief Medical Officer; Takeda/Tigenix: Consulting Fee: Consulting

Program Committee and Disclosures

CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure

Members

David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure

Ex-Officios

Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure

Consultants

Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 1.5 credits meets the requirements for Self-Assessment.

American College of Surgeons and ACGME Logos

Note: Residents will receive a Certificate of Completion.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Certificate of Completion
  • 1.50 Self Assessment Credit
Please login or register to take this course.

This course is available as part of the Clinical Congress 2019 Webcast Packages